MedTrace Logo

Clinical Trial to Evaluate the Reduction of Cardiovascular Risk

NCT04114916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-10-03

No results posted yet for this study

Summary

Randomized parallel and double blind clinical trial in which it is intended to analyze the efficacy of a nutraceutical on cholesterol and endothelial function after the consumption of a product for eight weeks.

Conditions

  • Cholesterol

Interventions

DIETARY_SUPPLEMENT

Apigenin, luteonin, grapefruit extract and citrolive

Two capsules daily at breakfast and dinner.

DIETARY_SUPPLEMENT

maltodextrina

Two capsules daily at breakfast and dinner.

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2018-12-22
Completion
2018-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04114916 on ClinicalTrials.gov